Literature DB >> 33248383

Role of brain natriuretic peptide in the prediction of long-term surgical outcome of chronic subdural hematoma.

Mehdi Chihi1, Oliver Gembruch2, Marvin Darkwah Oppong2, Laurèl Rauschenbach2, Steffen Rauscher2, Ramazan Jabbarli2, Karsten H Wrede2, Ulrich Sure2, Homajoun Maslehaty2.   

Abstract

OBJECTIVE: To investigate the role of brain natriuretic peptide (BNP) in predicting long-term functional outcome and develop a new predictive score of poor functional outcome after surgery for chronic subdural hematoma (cSDH).
METHODS: Patients with cSDH that were surgically treated in our department between November 2016 and December 2019 were included in the study. Pre- and postoperative plasma BNP and clinical condition were prospectively recorded. At follow-up (5-6 months), a simplified modified Rankin Scale (mRS) questionnaire was conducted through a standardized telephone interview. A poor outcome was defined by a mRS > 3. Based on predictors of the long-term functional outcome, a score was calculated. Its accuracy was tested using the area under the curve (AUC) of the receiver operating characteristic analysis.
RESULTS: In total, 119 patients were analyzed (median age: 76 years, range: 44-94 years). Preoperative plasma BNP (BNP-1) was elevated in 77 patients (64.7%). For the follow-up phone interview, 101 patients (84.8%) were available. In the multivariate analysis, poor outcome at follow-up could be predicted using BNP-1 (p = 0.034), age (p = 0.036), motor deficit (p = 0.013) and Glasgow coma scale score on admission (p = 0.008). The "Functional Long-term Outcome Predictive score" (FLOP-score) was therefore computed, and revealed an excellent discriminative capacity compared to other scores, with an AUC of 0.86 (0.77-0.95).
CONCLUSIONS: Preoperative plasma BNP is an independent predictor of functional outcome at follow-up. Using the FLOP-score, the risk of experiencing a poor outcome could accurately be predicted.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Brain natriuretic peptide; Chronic subdural hematoma; Outcome; Trauma

Mesh:

Substances:

Year:  2020        PMID: 33248383     DOI: 10.1016/j.jns.2020.117240

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  The Combination Clinical Value of Plasma Brain Natriuretic Peptide and Serum HbAlc in the Diagnosis of Chronic Pulmonary Heart Disease.

Authors:  Enxia Jia
Journal:  Comput Math Methods Med       Date:  2022-06-20       Impact factor: 2.809

2.  Serum Levels of MMP-8 and MMP-9 as Markers in Chronic Subdural Hematoma.

Authors:  Gao-Jian Su; Jie Gao; Chu-Wei Wu; Jun-Feng Zou; Di Zhang; Dong-Liang Zhu; Jun Liu; Jie-Hua Zhang; Xian-Jian Huang
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

3.  External validation of prognostic models predicting outcome after chronic subdural hematoma.

Authors:  Dana C Holl; Ana Mikolic; Jurre Blaauw; Roger Lodewijkx; Merijn Foppen; Korné Jellema; Niels A van der Gaag; Heleen M den Hertog; Bram Jacobs; Joukje van der Naalt; Dagmar Verbaan; K H Kho; C M F Dirven; Ruben Dammers; Hester F Lingsma; David van Klaveren
Journal:  Acta Neurochir (Wien)       Date:  2022-05-03       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.